Track the Nykode Therapeutics ASA share price and the full management transaction log of the company, a listed issuer based in Norway. Shares are quoted on the NO market, under the authority of Oslo Børs. Operating in the Health Care sector, Nykode Therapeutics ASA has logged 55 reports. The latest transaction was disclosed on 31 August 2026 (Other). Among the most active insiders: Michael Engsig. All data is openly available.
55
Insider Decl.
n/a
Thresholds
€47m
25 ops.
Buy Volume
€23m
9 ops.
Sell Volume
10Σ signal
Buys €47m€23m Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ NOK 16.3616.1% of flowShareXOSLOSLO:602442
25 of 55 declarations
Acerca de Nykode Therapeutics ASA
Nykode Therapeutics ASA es una empresa biofarmacéutica centrada en el desarrollo de inmunoterapias para el tratamiento del cáncer y las enfermedades infecciosas. Cotiza en el mercado XOSL.